SAN FRANCISCO -- For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, there was no clinical benefit to a strategy of finding and treating all nonculprit ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback